USU wins Liechtensteinische Landesbank as a new customer in the IT Management segment
Möglingen, March 17, 2021 Liechtensteinische Landesbank AG (LLB) will use USU software and services to…
Möglingen, March 17, 2021 Liechtensteinische Landesbank AG (LLB) will use USU software and services to…
Warrington, United Kingdom, 17 March 2021: MDS Global Ltd, a leading BSS-as-a-Service provider, has today…
Contact centre solution provider partners with Avoira to add emotion-detecting software to comprehensive feature set…
Gosselies, Belgium, 17 March 2021, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the…
PRESS RELEASE Financial highlights Jan – Dec 2020 (Jan – Dec 2019 restated)Revenue was SEK…
CAMBRIDGE Mass., March 16, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (NASDAQ: RUBY) (“Rubius”), a…
POSEIDON – positive interim results in Q4 2020; additional interim results expected in Q2 2021…
SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE), announced today…
cobas® pure integrated solutions brings together three diagnostic technologies1 on a single platform to optimise…
Company to host conference call and webcast at 5:00 p.m. ET MENLO PARK, Calif., March…
–Calithera to Provide Corporate Update via Conference Call and Webcast at 2:00 p.m. PT on…
BOSTON, March 16, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused…
JERUSALEM , March 16, 2021 (GLOBE NEWSWIRE) — Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or…
Management will host a conference call today at 4:30 p.m. (ET) to review financial results…
CANTON, Mass., March 16, 2021 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
– PLN-74809 Phase 2a PET Imaging Trial Resumed, with Preliminary Data Expected First Half of…
DEER PARK, Ill., March 16, 2021 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), an…
EMERYVILLE, Calif., March 16, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader…
BERKELEY HEIGHTS, N.J., March 16, 2021 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP;…
Signed new 12-month committed volume contracts with two prominent U.S. medical centers Reported progress on…